West Pharmaceutical Services | WST - Beneficio Bruto En Ventas

Precio De Mercado
256.55
Cambio Diario
-1.99 -0.77%
Mensual
7.68%
Anual
21.76%
Q2 Expectativa
249.55




Beneficio Bruto En Ventas Cambio Fecha
Align Technology USD 683.59M 44.39M 2025-12
Avanos Medical USD 86M 0 2025-12
Baxter International USD 577M 373M 2025-12
Becton, Dickinson and Co. USD 2.41B 1.72B 2025-12
Cerus USD 33.33M 8.66M 2024-12
Charles River Laboratories USD 271.96M 39.43M 2025-12
Cooper Companies USD 695.2M 44.4M 2025-12
Dentsply International USD 443M 2M 2025-12
Haemonetics USD 202.39M 7.64M 2025-12
ICU Medical USD 202.98M 2.1M 2025-12
Insulet USD 568.6M 58.5M 2025-12
Integra LifeSciences USD 217.1M 10.11M 2025-12
IQVIA Holdings USD 1.12B 32M 2025-12
J&J USD 16.6B 118M 2025-12
Medtronic USD 5.41B 27M 2025-12
Merit Medical Systems USD 195.35M 8.94M 2025-12
Neogen USD 99M 7.7M 2025-12
OraSure Technologies USD 11.34M 435K 2025-12
Quidel USD 274.8M 1.01B 2025-12
Repligen USD 103.83M 3.32M 2025-12
Rockwell Medical USD 4.55M 1.49M 2024-06
Solventum Corp USD 1.03B 108M 2025-12
STAAR Surgical USD 43.74M 34.13M 2025-12
Terumo JPY 153.19B 6.2B 2025-12
Utah Medical Products USD 5.8M 450K 2024-09
West Pharmaceutical Services USD 303.9M 9.6M 2025-12